Prostate Cancer - Results from #22040

Bone-targeted therapies in metastatic castration-resistant prostate cancer: Evolving paradigms - Abstract October 25, 2013

A prospective analysis of penile length changes following radical prostatectomy - Abstract October 25, 2013

The prognostic value of percentage of positive biopsy cores, percentage of cancer volume, and maximum involvement of biopsy cores in prostate cancer patients receiving proton and photon beam therapy - Abstract October 25, 2013

Pathological and oncological outcomes of elderly men with clinically localized prostate cancer - Abstract October 24, 2013

Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer - Results of a phase IIb randomized controlled trial - Abstract October 24, 2013

Positive surgical margins at radical prostatectomy: Population-based averages within PSA and Gleason strata - Abstract October 24, 2013

Needle biopsy size and pathological Gleason score diagnosis: No evidence for a link - Abstract October 24, 2013

Stereotactic body radiotherapy in prostate cancer: Is Rapidarc a better solution than Cyberknife? - Abstract October 24, 2013

Safety of abiraterone acetate in castration-resistant prostate cancer patients with concomitant cardiovascular risk factors - Abstract October 24, 2013

Urologists' use of intensity-modulated radiation therapy for prostate cancer - Abstract October 24, 2013

Functional and oncological outcomes of patients younger than 50 years treated with radical prostatectomy for localized prostate cancer in a European population - Abstract October 24, 2013

Focal cryoablation: A treatment option for unilateral low-risk prostate cancer - Abstract October 24, 2013

Comparison of interreader reproducibility of the Prostate Imaging Reporting and Data System and Likert scales for evaluation of multiparametric prostate MRI - Abstract October 24, 2013

MRI-targeted prostate biopsy: A review of technique and results - Abstract October 24, 2013

Statin use and incident prostate cancer risk: Does the statin brand matter? A population-based cohort study - Abstract October 24, 2013

Transperineal template-guided biopsy for diagnosis of prostate cancer in patients with at least two prior negative biopsies - Abstract October 24, 2013

Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer - Abstract October 24, 2013

Time to nadir PSA: Of popes and PSA-The immortality bias - Abstract October 23, 2013

Combined treatment effects of radiation and immunotherapy: Studies in an autochthonous prostate cancer model - Abstract October 23, 2013

Mortality and complications following prostate biopsy in the PLCO Cancer Screening trial - Abstract October 23, 2013

Page 1103 of 1438